YY [YY] SC 13G: SCHEDULE 13G ————————- ————————- CUSIP NO. 98426T106 Page

[SCHEDULE 13G ------------------------- ------------------------- CUSIP NO. 98426T106 Page 4 of 5 -------------------------------------------------------------------------------- Item 4. Ownership --------- Provide the following information regarding thegregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 12,820,000 Class Ammon Shares (b) Percent of class: 7.1% (c) Number of shares to]

MR [Mindray Medical International] SC 13G: CUSIP No.602675100 1. Names of Reporting Persons. I.R.S.

[CUSIP No.602675100 1. Names of Reporting Persons. I.R.S. Identification Nos. ofove persons (entities only) 2. Check the Appropriate Box if a Member of a (See Instructions) (a) o (b) o 3. SEC Use Only 4. Citizenship or Place of Organization Number of 5. Sole Voting Power 6. Shared Voting Power]

BIDU [Baidu] SC 13G: 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 1,375,529 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED]

Skip to toolbar